Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Modern Rheumatology|October 3, 2022
Clinical characteristics of rheumatoid arthritis patients complicated with pulmonary nontuberculous mycobacterial disease: A cross-sectional case series studyYoichi Nakayama, Eisaku Tanaka, Masakuni Ueyama, et al.
Internal Medicine (Tokyo, Japan)|July 16, 2009
Pulmonary thrombosis with transient antiphospholipid syndrome after mononucleosis-like illnessKiminobu Tanizawa, Daisuke Nakatsuka, Eisaku Tanaka, et al.
Idcases|February 2, 2024
Successful treatment of streptococcal toxic shock syndrome complicated by primary peritonitis and bilateral empyema in a healthy young woman: Identification of uncommon clone <i>emm103</i> and novel sequence type 1363Yoshihiko M Sakaguchi, Koichiro Murakami, Hiroyuki Akebo, et al.
Respiratory Medicine|March 15, 2013
The prognostic value of HRCT in myositis-associated interstitial lung diseaseKiminobu Tanizawa, Tomohiro Handa, Ran Nakashima, et al.
Modern Rheumatology|December 31, 2011
Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in JapanShunsuke Mori, Hitoshi Tokuda, Fumikazu Sakai, et al.
Internal Medicine (Tokyo, Japan)|February 18, 2011
Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter studyHideto Kameda, Hitoshi Tokuda, Fumikazu Sakai, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 17, 2019
Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive DermatomyositisHideaki Tsuji, Ran Nakashima, Yuji Hosono, et al.
Rheumatology (Oxford, England)|March 10, 2019
Serum matrix metalloproteinase levels in polymyositis/dermatomyositis patients with interstitial lung diseaseYoshinari Nakatsuka, Tomohiro Handa, Ran Nakashima, et al.
Respiratory Medicine|May 3, 2017
The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodiesKiminobu Tanizawa, Tomohiro Handa, Ran Nakashima, et al.
Annals of the Rheumatic Diseases|October 21, 2019
Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trialYoshiya Tanaka, Koji Oba, Takao Koike, et al.
Pageof 4